EP2283161A4 - Methods for assessing colorectal cancer and compositions for use therein - Google Patents

Methods for assessing colorectal cancer and compositions for use therein

Info

Publication number
EP2283161A4
EP2283161A4 EP09747751A EP09747751A EP2283161A4 EP 2283161 A4 EP2283161 A4 EP 2283161A4 EP 09747751 A EP09747751 A EP 09747751A EP 09747751 A EP09747751 A EP 09747751A EP 2283161 A4 EP2283161 A4 EP 2283161A4
Authority
EP
European Patent Office
Prior art keywords
compositions
methods
colorectal cancer
assessing colorectal
assessing
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Withdrawn
Application number
EP09747751A
Other languages
German (de)
French (fr)
Other versions
EP2283161A2 (en
Inventor
Mitch Raponi
Greg M Arndt
Lesley Dossey
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Janssen Diagnostics LLC
Original Assignee
Janssen Diagnostics LLC
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Janssen Diagnostics LLC filed Critical Janssen Diagnostics LLC
Publication of EP2283161A2 publication Critical patent/EP2283161A2/en
Publication of EP2283161A4 publication Critical patent/EP2283161A4/en
Withdrawn legal-status Critical Current

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12QMEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q1/00Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
    • C12Q1/68Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving nucleic acids
    • C12Q1/6876Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes
    • C12Q1/6883Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes for diseases caused by alterations of genetic material
    • C12Q1/6886Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes for diseases caused by alterations of genetic material for cancer
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12QMEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q2600/00Oligonucleotides characterized by their use
    • C12Q2600/112Disease subtyping, staging or classification
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12QMEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q2600/00Oligonucleotides characterized by their use
    • C12Q2600/158Expression markers
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12QMEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q2600/00Oligonucleotides characterized by their use
    • C12Q2600/178Oligonucleotides characterized by their use miRNA, siRNA or ncRNA
EP09747751A 2008-05-16 2009-05-18 Methods for assessing colorectal cancer and compositions for use therein Withdrawn EP2283161A4 (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US5376008P 2008-05-16 2008-05-16
PCT/US2009/044282 WO2009140670A2 (en) 2008-05-16 2009-05-18 Methods for assessing colorectal cancer and compositions for use therein

Publications (2)

Publication Number Publication Date
EP2283161A2 EP2283161A2 (en) 2011-02-16
EP2283161A4 true EP2283161A4 (en) 2012-03-28

Family

ID=41319374

Family Applications (1)

Application Number Title Priority Date Filing Date
EP09747751A Withdrawn EP2283161A4 (en) 2008-05-16 2009-05-18 Methods for assessing colorectal cancer and compositions for use therein

Country Status (8)

Country Link
EP (1) EP2283161A4 (en)
JP (1) JP2011520454A (en)
KR (1) KR20110015013A (en)
BR (1) BRPI0911972A2 (en)
CA (1) CA2725477A1 (en)
IL (1) IL209078A0 (en)
MX (1) MX2010012542A (en)
WO (1) WO2009140670A2 (en)

Families Citing this family (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CA2814081A1 (en) * 2010-10-08 2012-04-12 Baylor Research Institute Micrornas (mirna) as biomakers for the identification of familial and non-familial colorectal cancer
ES2548039T3 (en) * 2010-12-01 2015-10-13 INSERM (Institut National de la Santé et de la Recherche Médicale) Prediction mode of the outcome of a colon cancer by analyzing miRNA expression
EP2778237A1 (en) * 2011-01-13 2014-09-17 Industrial Technology Research Institute Biomarkers for recurrence prediction of colorectal cancer
NO3051026T3 (en) * 2011-10-21 2018-07-28
JP6156621B2 (en) * 2012-02-14 2017-07-05 国立大学法人 岡山大学 Data acquisition method for ATLL diagnosis, ATLL diagnosis kit, and ATLL diagnosis system
WO2013160474A2 (en) * 2012-04-26 2013-10-31 Instituto Aragonés De Ciencias De La Salud miRNAs EXPRESSION IN HEMATOLOGICAL DISEASES
CA2939343A1 (en) 2014-02-18 2015-08-27 Baylor Research Institute Mir-320e and colorectal cancer

Citations (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2009059026A1 (en) * 2007-10-30 2009-05-07 Veridex, Llc Process for monitoring colorectal cancer

Patent Citations (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2009059026A1 (en) * 2007-10-30 2009-05-07 Veridex, Llc Process for monitoring colorectal cancer

Non-Patent Citations (3)

* Cited by examiner, † Cited by third party
Title
ARNDT GREG M ET AL: "Characterization of global microRNA expression reveals oncogenic potential of miR-145 in metastatic colorectal cancer", BMC CANCER, BIOMED CENTRAL, LONDON, GB, vol. 9, no. 1, 20 October 2009 (2009-10-20), pages 374, XP021062713, ISSN: 1471-2407, DOI: 10.1186/1471-2407-9-374 *
BANDRÉS E ET AL: "Identification by Real-time PCR of 13 mature microRNAs differentially expressed in colorectal cancer and non-tumoral tissues", MOLECULAR CANCER, BIOMED CENTRAL, LONDON, GB, vol. 5, 19 July 2006 (2006-07-19), pages 29, XP002460700, ISSN: 1476-4598, DOI: 10.1186/1476-4598-5-29 *
JAY CHRIS ET AL: "miRNA profiling for diagnosis and prognosis of human cancer", DNA AND CELL BIOLOGY, MARY ANN LIEBERT, NEW YORK, NY, US, vol. 26, no. 5, 1 May 2007 (2007-05-01), pages 293 - 300, XP002510058, ISSN: 1044-5498, DOI: 10.1089/DNA.2006.0554 *

Also Published As

Publication number Publication date
WO2009140670A2 (en) 2009-11-19
CA2725477A1 (en) 2009-11-19
EP2283161A2 (en) 2011-02-16
MX2010012542A (en) 2010-12-21
KR20110015013A (en) 2011-02-14
JP2011520454A (en) 2011-07-21
WO2009140670A9 (en) 2010-03-18
BRPI0911972A2 (en) 2019-09-24
IL209078A0 (en) 2011-01-31

Similar Documents

Publication Publication Date Title
SI2173379T1 (en) Compositions and methods for treating and diagnosing cancer
HK1140944A1 (en) Methods and compositions for treating recurrent cancer
EP2310526A4 (en) Compositions for the detection and treatment of colorectal cancer
IL210153A0 (en) Nutrigenomics methods and compositions
EP2125887A4 (en) Compositions and methods for diagnosing and treating cancer
IL212822A0 (en) Anti-cxcr1 compositions and methods
GB0819530D0 (en) Methods and compositions
EP2155249A4 (en) Compositions and methods for diagnosing and treating cancer
HK1143157A1 (en) 4-pyridinone compounds and their use for cancer 4-
EP2079839A4 (en) Assessment of risk for colorectal cancer
HRP20130642T1 (en) Methods and compositions for treating cancers
IL209078A0 (en) Methods for assessing colorectal cancer and compositions for use therein
ZA201203325B (en) Methods and compositions for treating solid tumors and other malignancies
IL204945A0 (en) Compositions and methods for inhibiting tumor progression
IL217565A0 (en) Methods and kits used in assessing cancer risk
GB0811250D0 (en) Methods and compositions
EP2363499A4 (en) Colorectal cancer diagnostic method
GB0822345D0 (en) Methods and compositions for cancer prognosis
IL225959A0 (en) Methods and compositions for assessing and treating cancer
EP2632494A4 (en) Methods and compositions for assessing and treating cancer
ZA201100008B (en) Anti-tumour compositions and methods
GB0813352D0 (en) Cancer treatment and test
EP2252298A4 (en) Compositions and methods for treating lung cancer
IL210713A0 (en) Compositions and methods for determininig the prognosis of bladder urothelail cancer
GB0803464D0 (en) Methods and compositions

Legal Events

Date Code Title Description
PUAI Public reference made under article 153(3) epc to a published international application that has entered the european phase

Free format text: ORIGINAL CODE: 0009012

17P Request for examination filed

Effective date: 20101216

AK Designated contracting states

Kind code of ref document: A2

Designated state(s): AT BE BG CH CY CZ DE DK EE ES FI FR GB GR HR HU IE IS IT LI LT LU LV MC MK MT NL NO PL PT RO SE SI SK TR

AX Request for extension of the european patent

Extension state: AL BA RS

RAX Requested extension states of the european patent have changed

Extension state: AL

Payment date: 20101216

A4 Supplementary search report drawn up and despatched

Effective date: 20120223

RIC1 Information provided on ipc code assigned before grant

Ipc: C12Q 1/68 20060101AFI20120217BHEP

STAA Information on the status of an ep patent application or granted ep patent

Free format text: STATUS: THE APPLICATION IS DEEMED TO BE WITHDRAWN

18D Application deemed to be withdrawn

Effective date: 20120925